
    
      PROTOCOL OUTLINE: This is a randomized, double blind study. Patients are randomized to
      receive leuprolide acetate or gonadotropin releasing hormone (GnRH) first, then cross over to
      receive the other test.

      Patients receive one subcutaneous injection of leuprolide acetate or GnRH, then have blood
      samples drawn periodically. One month later, patients receive the other test.

      Another cohort of patients are randomized to receive leuprolide acetate once daily on days 0,
      4, and 8, or days 0, 5, and 10.

      Patients are followed for up to 2 years.

      Completion date provided represents the completion date of the grant per OOPD records
    
  